Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0QH3H
|
|||
| Former ID |
DIB014789
|
|||
| Drug Name |
DCVax-Prostate cancer vaccine
|
|||
| Synonyms |
DCVax + PSMA; PSMA + DCVax; Dendritic cell vaccine (prostate cancer), Northwest; PSMA-treated dentritic cells, Northwest; Vaccine (prostate cancer), Pacific Northwest
Click to Show/Hide
|
|||
| Indication | Prostate cancer [ICD-11: 2C82.0; ICD-10: C61; ICD-9: 185] | Phase 2 | [1], [2] | |
| Diabetic neuropathy [ICD-11: 8C0Z; ICD-10: G63, G63.2] | Discontinued in Phase 3 | [3] | ||
| Company |
Northwest biotherapeutics
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 3 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008981) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.